Sales Growth YoY (Last Twelve Months): Rhythm Corp (RYTM)

Graphic logo of Rhythm Pharmaceuticals (RYTM)

Rhythm Pharmaceuticals (RYTM) maintains a monopoly in the rare obesity segment, eliminating therapy alternatives and defining the company's financial strategy. Sales volume growth compared to the same period last year over the past 12 months serves as a confidence indicator, where the 61.50 metric reflects current dynamics. The business relies on contract peptide manufacturing and depends on external supplies, while maintaining a minimal environmental footprint due to its focus on intellectual property development.

Sales Growth YoY (Last Twelve Months): Rhythm Pharmaceuticals Inc (RYTM) for 02/11/2024 - 11/17/2026

Summary analytical data breakdowns for Rhythm Pharmaceuticals, Inc. (RYTM)

- market value and analyst target forecast:
- company stock exchange capitalization indicators:
Summary company analytics:Rhythm Pharmaceuticals
Mass-produced product of rhythmtx.com

Rhythm Pharmaceuticals effectively scales the distribution of orphan drugs through flexible outsourcing of production to external contractors. Analyzing the rolling year-over-year revenue growth chart, an investor sees the current value of 61.50. This metric aggregates sales over twelve months with daily updates, which neutralizes market noise and exposes the real distribution dynamics. The stable trend confirms the resilience of the commercial flow and the strength of the business model.

Competitor analysis for Rhythm Pharmaceuticals

Ascendis (ASND) - Trailing Twelve Months Revenue Growth|MDGL - Sales Growth YoY (Last Twelve Months)|CORT: Sales Growth YoY (Last Twelve Months)|AKRO: Sales Growth YoY (TTM)|MTSR - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) MoonLake Corp|Crinetics Corp (CRNX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) newamsterdampharma.com (NAMS)|Revenue Growth YoY (Last 12 Months) soleno.life SLNO|Sales Growth YoY (TTM) FOLD (amicusrx.com)|Annual Revenue Growth (Last Twelve Months) 89bio (ETNB)|Agios - Sales Growth YoY (TTM)|Structure Corp - Revenue Change YoY (Last 12 Months)|mimedx.com (MDXG) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Sales Growth RZLT (rezolutebio.com)|LXRX (Lexicon Pharmaceuticals Inc) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) MBX|Sales Growth YoY (Last Twelve Months) Altimmune Pharma (ALT)|Sales Growth YoY (Last Twelve Months) AARD (Aardvark Therapeutics Corp)|Sales Growth YoY (TTM) SGMT (Sagimet Biosciences, Inc.)|BioAge (BIOA) - Trailing Twelve Months Revenue Growth|BMEA: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) QNCX (Quince Therapeutics Inc)|GUTS (Fractyl) - Revenue Growth YoY (Last 12 Months)|vTv Therapeutics, Inc. - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Agape ATP Corp.|Revenue Growth YoY (Last 12 Months) Pluri (PLUR)|Sales Growth YoY (TTM) SYBX|Annual Revenue Growth (Last Twelve Months) Lipocine Inc|Sales Growth YoY (Last Twelve Months) Matinas BioPharma Holdings MTNB|Annual Revenue Growth (Last Twelve Months) Spruce Biosciences (SPRB)|GLTO: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Sales Growth CTCX|LUMO (Lumos Pharma) - Revenue Growth YoY (Last 12 Months)|Sales Growth YoY (Last 12 Months) ONVO|RDUS (Radius Pharmaceuticals) - Sales Growth YoY (TTM)